Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
New Board of Directors and management team at Suven Pharma also appointed
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
The delegation's visit covered a wide range of topics
Subscribe To Our Newsletter & Stay Updated
